Europe · More sources · Euronews Business
AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan
AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year…
Read the full article on Euronews Business Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.euronews.com)





